8–12%
Promoted by fish oil manufacturers and the laboratories that market the test
The strongest case for it
Red cell membrane omega-3 content is a genuine measure of long-term intake, and low levels are associated with higher cardiovascular mortality in observational cohorts.
What it leaves out
The target range was defined by researchers with commercial ties to the test and to supplementation, and large omega-3 supplementation trials have produced mixed and mostly modest results. The 'optimal' zone here is unusually close to being an artifact of the people selling it.